IBEC Seminar: Hiroshi Ishida, Tokyo University of Agriculture and Technology
Active Flow Generation for Mobile Robot Olfaction and Olfactory Assisting Devices
Search Results for:
IBEC Seminar: Hiroshi Ishida, Tokyo University of Agriculture and Technology
Active Flow Generation for Mobile Robot Olfaction and Olfactory Assisting Devices
IBEC Seminar: Hiroshi Ishida, Tokyo University of Agriculture and Technology
Active Flow Generation for Mobile Robot Olfaction and Olfactory Assisting Devices
IBEC Seminar: Hiroshi Ishida, Tokyo University of Agriculture and Technology
Active Flow Generation for Mobile Robot Olfaction and Olfactory Assisting Devices
IBEC Seminar: Ina Meiser, Cryobiotechnology group manager, IBMT
Application-oriented cryopreservation and banking of stem cells and stem cell derivates
IBEC Seminar: Ina Meiser, Cryobiotechnology group manager, IBMT
Application-oriented cryopreservation and banking of stem cells and stem cell derivates
IBEC Seminar: Ina Meiser, Cryobiotechnology group manager, IBMT
Application-oriented cryopreservation and banking of stem cells and stem cell derivates
IBEC Seminar: Ina Meiser, Cryobiotechnology group manager, IBMT
Application-oriented cryopreservation and banking of stem cells and stem cell derivates
BBVA funds IBEC research into more efficient cancer drug delivery systems
An IBEC project has won funding from the BBVA Foundation under its ‘Ayudas a Equipos de Investigación en Biomedicina’ funding programme.
An IBEC project has won funding from the BBVA Foundation under its ‘Ayudas a Equipos de Investigación en Biomedicina’ funding programme.ICREA research professor Samuel Sánchez’s Smart Nano-Bio-Devices group will receive the support for three years to develop their project ‘MEDIROBOTS: Precision nanobotomy against tumors’.
The project will develop biocompatible robots driven by enzymes with applications as drug release systems whose progress in vitro and in vivo can be traced using advanced molecular imaging techniques such as super-resolution microscopy.
Biomaterials as signal-releasing platforms
IBEC’s Biomaterials for Regenerative Therapies group has published a review of the state-of-the-art in biomaterials for skin healing that proposes a move towards more personalized, in situ therapies.
IBEC’s Biomaterials for Regenerative Therapies group has published a review of the state-of-the-art in biomaterials for skin healing that proposes a move towards more personalized, in situ therapies.Skin wound healing repairs and restore tissue through a complex process that involves different cells and signalling molecules that regulate cellular response and the remodelling of the extracellular matrix. Publishing in Advanced Drug Delivery Reviews, the article begins by summarizing recent advances in therapies for healing that combine biomolecule signals such as growth factors and cytokines with cells.